GI14-191
A Randomized Phase II Trial to Evaluate the Efficacy of Supportive Therapy with Ginseng for Patients on Treatment with Regorafenib: HCRN GI14-191.
For full description, see www.clinicaltrials.gov.
A Randomized Phase II Trial to Evaluate the Efficacy of Supportive Therapy with Ginseng for Patients on Treatment with Regorafenib: HCRN GI14-191.
For full description, see www.clinicaltrials.gov.
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter